Mayo claims that in early MS with mild symptoms,
no treatment is necessary. This flies in
the face of what is generally agreed to by other MS facilities, that treating MS early provides patients with the best chance of slowing down the disease process, minimizing the number of releases in RRMS, and mitigating permanent neurological damage.